A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Trial Profile

A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Rifaximin (Primary) ; Lactulose
  • Indications Hepatic encephalopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2016 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
    • 18 Aug 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016, as reported by ClinicalTrials.gov.
    • 18 Aug 2015 Status changed from recruiting to not yet recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top